Advertisement

Inhibition of Aortic Vessel Adenosine Diphosphate Degradation by Cadmium and Mercury

  • G. Togna
  • N. Dolci
  • L. Caprino
Part of the Archives of Toxicology book series (TOXICOLOGY, volume 7)

Abstract

The effects of cadmium and mercury on ADP breakdown by vessel walls were investigated. These metals reduce the ADP clearance promoted by arterial tissue. This effect could be attributed to the inhibition of vessel wall ADP-ase enzyme, which plays an important role in the genesis of thrombotic phenomena.

Key words

Mercury Cadmium Blood vessel ADP degradation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berry JP (1972) Les lésions rénales provoqueés par le cadmium. Etude au microscope électronique et au micro-analyseur a sonde électronique. Pathol Biol (Paris) 20: 401–412Google Scholar
  2. Caprino L, Togna G (1979) Inhibition of prostacyclin-like material formation by cadmium. Toxicol Appl Pharmacol 48: 529–531PubMedCrossRefGoogle Scholar
  3. Caprino L, Togna G, Togna AR (1979) Cadmium-induced platelet hypersensitivity to aggregating agents. Pharmacol Res Commun 11: 731–737PubMedCrossRefGoogle Scholar
  4. Caprino L, Dolci N, Togna G, Villa P, Bucci R, Carunchio V (1982a) Effects of cadmium on platelet thromboxane and vascular prostacyclin production. Toxicol Appl Pharmacol 65: 185–188PubMedCrossRefGoogle Scholar
  5. Caprino L, Antonetti F, Borrelli F, Morelli L (1982b) In vitro activity of urokinase on platelet function and on ADP degradation by vascular tissue. Thromb Res 27: 447–456PubMedCrossRefGoogle Scholar
  6. Caprino L, Togna AR, Cebo B, Dolci N, Togna G (1983) In vitro effects of mercury on platelet aggregation and thromboxane and vascular prostacyclin production. Arch Toxicol Suppl 6:48–51PubMedGoogle Scholar
  7. Cooper DR, Lewis GP, Lieberman GE, Webb H, Westwich J (1979) ADP metabolism in vascular tissue. A possible-regulatory mechanism. Thromb Res 14: 901–914PubMedCrossRefGoogle Scholar
  8. Lieberman GE, Lewis GP, Peters TJ (1977) A membrane bound enzyme in rabbit aorta capable of inhibiting ADP-induced platelet aggregation. Lancet 2: 330–332PubMedCrossRefGoogle Scholar
  9. Perry HM Jr, Erlanger MW (1974) Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury. J Lab Clin Med 83: 541–547PubMedGoogle Scholar
  10. Porter MC, Miya TS, Bousquet WF (1975) Cadmium and vascular reactivity in the rat. Toxicol Appl Pharmacol 34:143–150PubMedCrossRefGoogle Scholar
  11. Revis NW, Zinsmeister AR, Bull R (1981) Atherosclerosis and hypertension induction by lead and cadmium ions. Proc Natl Acad Sci USA 78: 6494–6498PubMedCrossRefGoogle Scholar
  12. Robinson CW, Kress SC, Wagner RH, Brinkhous KM (1965) Platelet agglutination and deagglutination with a sulphydryl inhibitor, methyl mercuric nitrate: Relationships to platelet ATPase. Exp Mol Pathol 4: 457–464PubMedCrossRefGoogle Scholar
  13. Schlaepfer WW (1971) Sequential study of endothelial changes in acute cadmium intoxication. Lab Invest 25: 556–564PubMedGoogle Scholar
  14. Shaper AG (1979) Cardiovascular disease and trace metals. Proc R Soc Lond [Biol] 205:135–143CrossRefGoogle Scholar
  15. Singhal RL, Merali Z (1979) Biochemical toxicity of cadmium. In: Mennear JH (ed) Cadmium toxicity. Dekker, New York, pp 61–112Google Scholar
  16. Vallee BL, Ulmer DD (1972) Biochemical effects of mercury, cadmium and lead. Ann Rev Biochem 41:91–128PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • G. Togna
    • 1
  • N. Dolci
    • 1
  • L. Caprino
    • 2
  1. 1.Institute of HygieneCatholic UniversityRomeItaly
  2. 2.Institute of PharmacologyCatholic UniversityRomeItaly

Personalised recommendations